BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 13, 2020
View Archived Issues
Enrollment ongoing in phase I/II ASPEN-02 study of ALX-148 plus azacytidine in MDS
Read More
Oncostellae initiates phase Ib/IIa study of OST-122 in ulcerative colitis
Read More
Venthera begins first-in-human trial of VT-30
Read More
Drug repurposing study suggests paromomycin as a dual targeting drug against SARS-CoV-2
Read More
FKBP9P1 lncRNA is upregulated in HNSCC and its knockdown inhibits malignant progression
Read More
Microbiome metabolite affects neuropathic pain
Read More
Prying the BBB back open for improved LSD treatment
Read More
Dosing starts in phase I study of AMP-945
Read More
PENELOPE-B study of palbociclib does not meet primary endpoint
Read More
Potential MND treatments move a step forward
Read More
Galectin-7, a new biomarker for pre-eclampsia
Read More
UBAP2 as potential therapeutic target in pancreatic cancer
Read More
FDA clears IND for trials of ASC-42 for NASH
Read More
FDA issues complete response letter for Avenue's intravenous tramadol
Read More
Sorrento licenses PSC's mesenchymal stem cells for COVID-19-associated ARDS
Read More
Pivotal trial of Dupixent in children with moderate to severe asthma meets primary endpoint
Read More
SynAct advances phase IIa study of AP-1189 in rheumatoid arthritis
Read More
AstraZeneca advances AZD-7442 into phase III for COVID-19
Read More
Memorial Sloan Kettering, HHS patent ADAM 17-binding molecules
Read More
Celltrion begins phase III postexposure prophylaxis trial of CT-P59 for COVID-19
Read More
Janssen Pharmaceutica discloses new MAP4K1 inhibitors
Read More
New HDAC6 inhibitors discovered at 2681603 Ontario
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical present new ERK inhibitors
Read More
Axis Therapeutics collaborates with PharmaEssentia on TCR-T cell therapy in Taiwan
Read More
Registrational trial of penpulimab for nasopharyngeal cancer meets key endpoints
Read More
Promising cohort 2 data reported from pivotal study of Padcev in urothelial cancer
Read More
Topline data reported from EAP study with aviptadil for critical COVID-19
Read More
Phase I/II study of PLX-PAD for GvHD cleared to advance to cohort 2
Read More
New phase III trial evaluates hIVIG to treat COVID-19
Read More
